16 min listen
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
ratings:
Length:
61 minutes
Released:
Sep 1, 2023
Format:
Podcast episode
Description
Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/HigherRiskProstate)
CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/HigherRiskProstate)
Released:
Sep 1, 2023
Format:
Podcast episode
Titles in the series (100)
COVID-19 and Prostate Cancer: COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor. by Oncology Today with Dr Neil Love